Electroacupuncture Shows Promise in Relieving Cancer Pain

Electroacupuncture, a form of acupuncture using weak electrical stimulation, has been gaining attention as a potential alternative to opioids for relieving cancer pain. A clinical trial in South Korea aims to evaluate the pain relief response from a single session of electroacupuncture treatment, exploring its effectiveness in reducing cancer pain. The study, registered with the Clinical Research Information Service (CRiS), will analyze biosignal changes before and after electroacupuncture treatment to identify correlations between pain relief and physiological markers. With cancer pain being a common symptom affecting quality of life and prognosis, finding alternative treatments with fewer side effects is crucial.

Key Takeaways:

• The clinical trial, KCT0010941, aims to evaluate the pain relief response from a single session of electroacupuncture treatment in patients with cancer pain.
• The study will systematically analyze biosignal changes before and after electroacupuncture treatment to explore the correlation between pain relief and physiological markers.
• Cancer pain is a common symptom in cancer patients, affecting both quality of life and prognosis, with opioids commonly used for relief but having significant side effects.
• Electroacupuncture has emerged as a promising alternative treatment for cancer pain, showing positive results in various studies.
• The study will recruit patients with cancer pain and apply 2Hz electroacupuncture to the deep peroneal nerve, median nerve, and radial nerve for 15 minutes.
• Biosignals will be collected using devices to analyze the pain response.
• The study aims to provide foundational data for the development of future pain monitoring and response prediction algorithms.
• The trial will investigate the duration of pain relief from electroacupuncture and response and non-response patterns in cancer pain.
• Understanding patient characteristics and correlating them with biosignals related to response is crucial for the development of effective pain management strategies.

Statistics:

• The study aims to recruit cancer patients for the trial.
• The electroacupuncture treatment will be applied for 15 minutes.
• The study will analyze biosignal changes before and after treatment.
• Cancer pain affects both quality of life and prognosis in cancer patients.
• 2Hz electroacupuncture will be applied to the deep peroneal nerve, median nerve, and radial nerve.

Sources:

• Clinical Research Information Service (CRiS) - Republic of Korea
• Clinical trial registration number: KCT0010941
• https://cris.nih.go.kr/cris/search/detailSearch.do?seq=30705&search_page=L (Clinical trial full-text)
• https://contify.com (Copyright 2017)